Specific Contract for the Supply of the Drug Soliris 300Mg (Active Ingredient Eculizumab),... Tender

IRCCS FOUNDATION BESTA NEUROLOGICAL INSTITUTE has floated a tender for Specific Contract for the Supply of the Drug Soliris 300Mg (Active Ingredient Eculizumab), through the Use of the Sintel - Sda Platform. The project location is Italy and the tender is closing on 03 Sep 2025. The tender notice number is Besta_2025_205_PE, while the TOT Ref Number is 125278320. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country: Italy

Summary: Specific Contract for the Supply of the Drug Soliris 300Mg (Active Ingredient Eculizumab), through the Use of the Sintel - Sda Platform

Deadline: 03 Sep 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 125278320

Document Ref. No.: Besta_2025_205_PE

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: EUR 1042688.00

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Specific contract for the supply of the drug soliris 300mg (active ingredient Eculizumab), through the use of the Sintel - SDA platform

Earnest Money : 1.042.688, 00 €
Published Date : 27/08/2025
Submission Date : 03/09/2025 12:00

Documents

 Tender Notice


Procurement Documents for Italy

Access a comprehensive library of standard procurement documents specific to Italy. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in Italy

Explore Procurement Documents for Italy


Want To Bid in This Tender?

Get Local Agent Support in Italy and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?